Gonorrhea in China shows waning susceptibility to WHO-recommended antibiotics

(PLOS) Neisseria gonorrhoeae strains resistant to azithromycin and/or with decreased susceptibility to ceftriaxone are common in China, according to a prevalence study published this week in PLOS Medicine. The study also showed that the prevalence of dual resistance in N. gonorrhoeae isolates increased from 2013 to 2016. The results suggest that dual therapy with azithromycin and ceftriaxone, recommended by WHO and many countries to treat gonorrhea, may not prove effective in China.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news

Related Links:

Source: International Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Source Type: research
Though the comparison is a bit apples and oranges between now and 1918, the staggering death toll is tragic in any era.Medscape Medical News
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news
A new report claims better federal government coordination is needed, along with an improved public health infrastructure, more tests, and better data on critical supplies.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
Pediatric Dermatology Part I
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
Esther E. Freeman and Devon E. McMahon
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
BRUCE H. THIERS, MD
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
ELSEVIER
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
DERMATOLOGIC CLINICS
Source: Dermatologic Clinics - Category: Dermatology Authors: Source Type: research
Source: The American Journal of Cardiology - Category: Cardiology Source Type: research
Source: The American Journal of Cardiology - Category: Cardiology Source Type: research
More News: Azithromycin | Ceftriaxone | China Health | Infectious Diseases | Rocephin | Study | Zithromax